
Merck, Pfizer team up on Phase III trials and future commercialization of Pfizer's SGLT2 inhibitor for Type II diabetes
Executive Summary
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com